Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

NCT02980510 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

219

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
DRUG: Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan

Sponsor

UNICANCER